The amount ofbudesonide suspension actually delivered to six subjects (aged 4-30 months) by a jet nebuliser and spacer system (System 22) was determined. Two nebulisations were performed in each subject using a filter at the exhalation outlet of the inhalation chamber. An inhalation filter was additionally attached between the facemask and the spacer in the first test. The drug was inhaled during the second test. The nebuliser equipment was washed with ethanol and the amount of drug deposited was determined.
dose (500 rig) of budesonide was found in the inhalation filter, increasing from nine to 19/o with increasing age. Approximately 75% of the nominal dose was found in the nebuliser equipment.
These findings must be considered when deciding the nominal dose of budesonide suspension to be given to infants and toddlers. The amount of drug not accounted for in test 1 (mean 32 R,g) may have escaped through the air entrainment hole on top of the spacer or remained in the respule.
The exact amount of drug deposited and its distribution within the lungs in our patients is not known. Silverman has argued that drug delivery by jet nebulisers to a freely breathing young infant is negligible.4 Watterberg et al, however, stressed that giving drugs by this route, albeit with a small yield, was not futile.5
The variation (approximately 10%) of dosage deposited in the nebuliser equipment was not greater than would be expected from commercially available systems. The finding that as little as 15-20% of the nominal dose was available under optimum conditions for inhalation by these patients is worrying, however.
Unfortunately there are limited ways of delivering inhalation steroids to toddlers and infants, though various spacer devices attached to metered dose inhalers do exist. As there is increasing concern about the propellant gases in the metered dose inhalers, nebuliser solutions or suspensions of drugs are becoming more important as a means of drug administration. Furthermore, Zainudin et al, measuring the deposition of bronchodilators in the lungs of adults, found a significantly higher peripheral deposition of drugs using a nebulised solution rather than dry powder or metered dose inhaler. 6 They also showed that gastrointestinal deposition was significantly lower with the nebulised solution compared with the metered dose inhalers, though the total amount of drug delivered by these two systems did not differ significantly. These results obtained in adults may not be directly transferable to children. It may be assumed, however, that the amount of respirable particles reaching the lungs rather than the gastrointestinal tract in infants is higher with nebulised rather than pressurised aerosol drug delivery.
An unexpected finding in our study was the discrepancy of drug deposition on the exhalation filters with an inhalation filter present or absent. This phenomenon was seen in all our subjects and a rationale for this is lacking. As the resistance in this hydrophobic filter is low it is unlikely that this influenced the results. It may be speculated that some of the drug 'stuck' to the inhalation filter which, when this was omitted, would be exhaled and deposited on the exhalation filter. This raises the question that our estimates of available drug to the subjects might even be too optimistic! When treating infants with inhaled corticosteroids it is imperative to keep the potential systemic side effects to a minimum. Thus even if the amount of drug delivered to the infant is similar using a metered dose inhaler with a spacer attached or a nebuliser, it seems advantageous to use a nebuliser for this type of drug. However, with as much as 80% loss of active drug with the current nebuliser systems, the costs of treatment could potentially be greatly reduced if more efficient delivery systems were available. The important conclusion to draw is that the huge loss of active drug to the delivery system must be considered when treatment dosage is determined for the individual patient. Furthermore it is important to establish which factors determine the drug delivery for inhalation with respect to the age and tidal volume of the patient. 
